ArticleClinical immunology (Orlando, Fla.)2018

Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.

Kent J Weinhold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.